Brief: Maat Pharma Receives State Funding For The Clinical Development Of Maat033

Maat Pharma SA

30/11/2023 17:04

Nov 30 (Reuters) - Maat Pharma SA  MAAT.PA :
    * MAAT PHARMA RECEIVES FUNDING FROM THE STATE FOR THE
CLINICAL
DEVELOPMENT OF MAAT033 AS PART OF THE FRANCE 2030 PLAN
    * IS ABOUT TO RECEIVE 7.4 MILLION EUROS FROM THE STATE
    * INITIAL PAYMENTS EXTENDING THE FINANCIAL STABILITY OF THE
COMPANY UNTIL THE END OF THE SECOND QUARTER OF 2024, SUBJECT TO
ACHIEVEMENT OF PROJECT MILESTONES
    * THIS WILL LEAD TO A NET INCREASE IN CASH OF 3.1 MILLION
EUROS
DURING THE FIRST HALF OF 2024

Source text for Eikon:  ID:nBw9GfLRta 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))